ACA
TMDX icon

Atlas Capital Advisors’s Transmedics TMDX Stock Holding History

Atlas Capital Advisors’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-500
Closed -$49.7K – 1097
2026
Q1 		$49.7K Hold
500
– – 0.01% 645
2025
Q4 		$60.8K Buy
+500
New +$62.7K 0.01% 598
2025
Q2 		$67K Hold
500
– – 0.01% 588
2025
Q1 		$33.6K Hold
500
– – ﹤0.01% 673
2024
Q4 		$31.2K Buy
+500
New +$46.5K ﹤0.01% 673

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Atlas Capital Advisors's TMDX Position: Q2 2026 in Review

Atlas Capital Advisors sold out of Transmedics (TMDX) in Q2 2026, closing a stake of 500 shares — an estimated $49.7K sold.

Atlas Capital Advisors first reported a position in TMDX in Q4 2024 and held it in 5 quarters. The position peaked at $67K in Q2 2025. 375 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • Atlas Capital Advisors reported no remaining Transmedics position as of Q2 2026 after selling out during the quarter.
  • Atlas Capital Advisors sold 500 Transmedics shares in Q2 2026, an estimated $49.7K.
  • Atlas Capital Advisors first reported a position in Transmedics in Q4 2024 and held it in 5 quarters.
  • Atlas Capital Advisors's Transmedics position peaked at $67K in Q2 2025.
  • 375 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Atlas Capital Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.